Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

NCT01061541 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilus Influenzae Type b

Interventions

BIOLOGICAL: Tritanrix™-HepB low thio /
BIOLOGICAL: Hib 2.5
BIOLOGICAL: Tritanrix™-HepB
BIOLOGICAL: Hiberix™
BIOLOGICAL: Unconjugated Hib vaccine (plain PRP)

Sponsor

GlaxoSmithKline